High-Dose Dexamethasone

DRUG3 trials

Sponsors

London Health Sciences Centre, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno, Shandong University

Conditions

Covid-19ITP - Immune ThrombocytopeniaRespiratory Distress Syndrome, AdultTonsillitis

Phase 2

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Shandong UniversityITP - Immune Thrombocytopenia

Start: 2023-09-15End: 2024-12-10Target: 100Updated: 2023-09-26

Phase 3

Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial

TerminatedNCT04395105

Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoCovid-19, Respiratory Distress Syndrome, Adult

Start: 2020-05-21End: 2021-05-21Updated: 2021-06-02

Phase 4

Perioperative Tonsillectomy Protocol Development

London Health Sciences CentreTonsillitis

Start: 2018-03-01End: 2021-09-30Target: 60Updated: 2021-02-18

Related Papers

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.

2021-03-16125 citations

High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.

2020-08-2623 citations